MOLDTKPAC

Management Guidance & Outlook - Management remains very positive about food and FMCG due to Panipat plant picking up clients and new products launching in Dec/Jan. - Company aims for a pharma turnover of INR50+ crores (reached INR24 crores in H1). - Vibe specialty closures are expected to contribute revenues in FY28, targeting $5-6 million top line with 30% EBITDA margin in 2 years. - Short-term finance costs are expected to normalize around 4%-4.2% once raw material prices stabilize. Current Scenario - Q2 FY27 sales volumes grew by 10.1% YoY and profits jumped by 36% YoY. - EBITDA per kg improved to INR46.5 compared to INR39 in the previous year. - Pharma grew by 26.3%, food and FMCG by 23.7%, paints by 9%, while lubricant packs declined by 12.3%. - October started on a strong note, marking it as one of the best months so far. Capex & Growth Drivers - Capital expenditure for the full year is expected to be around INR75 crores to INR80 crores. - New high-value segments like semiconductor trays (JEDEC trays) and auto-injector pens are being explored for long-term growth. - Consolidation of Hyderabad units has resulted in considerable cost savings and improved efficiencies.

- Mold-Tek Packaging Limited informed the exchanges regarding the availability of the audio recording for the investors conference call held on November 02, 2026. - The call was conducted to discuss the Q2FY27 financial results of the company. - The audio recording link has been made available on the company website.

Concall Schedule Concall Date: November 05, 2026 Concall Time: 09:00 AM IST Onwards

Mold-Tek Packaging Limited submitted its Investor Presentation for the quarter and half-year ended September 30, 2026. - Q2 FY27 Revenue stood at ₹274.23 Cr (31% growth YoY) and H1 FY27 Revenue at ₹574.68 Cr (28% growth YoY). - Q2 FY27 EBITDA reached ₹51.27 Cr (30% growth YoY) and H1 FY27 EBITDA at ₹107.70 Cr (24% growth YoY). - Q2 FY27 PAT reported at ₹21.07 Cr (36% growth YoY) and H1 FY27 PAT at ₹46.64 Cr (23% growth YoY). - Strong performance driven by thin-wall packaging growth (40%), pharma sector momentum (32% growth in H1), cost control measures, and plant consolidations.

- Q2 FY27 Revenue rose 30.73% YoY to ₹274.23 Cr; PAT grew 36.06% YoY to ₹21.09 Cr. - Sales volume increased 10.08% YoY to 11,028 MT; EBITDA grew 29.80% to ₹51.27 Cr. - Strong volume growth delivered by Pharma (+26.3%) and Food & FMCG (+23.7%) segments. - Expanding into trays, dosing pens, and semiconductor packaging.

Q2 FY27 Standalone Revenue ₹274.23Cr vs ₹209.76Cr (▲30.7% YoY) EBITDA ₹50.56Cr vs ₹39.11Cr (▲29.3% YoY) PAT ₹21.07Cr vs ₹15.48Cr (▲36.1% YoY) EBITDA Margin 18.44% vs 18.65% (▼21bps)

Concall Schedule Concall Date: November 2, 2026 Concall Time: 4:30 PM (IST)

- Mold-Tek Packaging Limited has allotted 3,32,28,914 fully paid-up bonus equity shares of face value ₹5 each. - Bonus issue is in the ratio of 1:1 (1 new equity share for every 1 existing share). - Allotment approved by board on October 12, 2026, following shareholder approval on September 21, 2026. - Post-bonus paid-up equity share capital increased to ₹33,22,89,140 consisting of 6,64,57,828 shares.

- Mold-Tek Packaging Limited received an Income Tax demand notice of Rs. 36,04,920 under Section 156 of the Income Tax Act, 1961 for Assessment Year 2021-22. - The notice was received on September 30, 2026. - The company stated there are no violations and is preparing submissions to respond to the authorities.

- Mold-Tek Packaging Limited has fixed October 09, 2026 as the Record Date for the purpose of allotment of Bonus Equity Shares. - Bonus issue is in the ratio of 1:1 (1 Bonus Equity Share for every 1 existing fully paid-up Equity Share). - Deemed date of allotment is October 12, 2026.

- ICRA Limited reaffirmed the long-term credit rating of Mold-Tek Packaging Limited at [ICRA] A+(Positive) with a Positive outlook for instruments totaling ₹228.00 crore. - The short-term rating for instruments totaling ₹12.00 crore has been reaffirmed at [ICRA] A1. - The total rated amount is ₹240.00 crore.

New Filing detected. See link for details.

- Book closure from September 15, 2026, to September 21, 2026 (inclusive) for the 29th Annual General Meeting and final dividend entitlement. - Record date for the final dividend and e-voting is September 14, 2026.

- Book Closure for the 29th Annual General Meeting and Final Dividend will be from September 15, 2026, to September 21, 2026. - The Record Date for determining entitlement to the Final Dividend and for AGM voting is fixed as September 14, 2026.

- The Board approved a 1:1 Bonus Issue of equity shares (₹5/- FV), subject to shareholder approval, from free reserves. - Recommended a Final Dividend of ₹3/- (60%) per equity share for FY 2025-26. - Approved increasing authorized share capital from ₹20 Crores to ₹40 Crores. - Appointed Mr. Rana Pratap Janumahanti as Whole Time Director and Mr. Chintamaneni Vasant Kumar Roy as Non-Executive Independent Director. - Approved convening the 29th Annual General Meeting on September 21, 2026.

- Board approved 1:1 bonus shares and recommended ₹3/- final dividend for FY 2025-26. - Authorized share capital increased from ₹20 Cr to ₹40 Cr. - Appointments: Mr. Rana Pratap Janumahanti as WTD, Mr. Chintamaneni Vasant Kumar Roy as Independent Director. - 29th AGM scheduled for September 21, 2026.

- Mold-Tek Packaging Limited proposed a 1:1 Bonus Issue of Equity Shares. This action, effective August 26, 2026, will double the paid-up equity capital from ₹16.61 Cr to ₹33.23 Cr. The company aims to reward shareholders and enhance share liquidity.

- Approved 1:1 Bonus Issue of equity shares of ₹5/- each, subject to shareholder approval. - Recommended a Final Dividend of ₹3/- per equity share (60%) for FY 2025-26. - Approved increasing Authorized Share Capital from ₹20 Crores to ₹40 Crores, subject to shareholder approval. - Appointed Mr. Rana Pratap Janumahanti as Whole Time Director and Mr. Chintamaneni Vasant Kumar Roy as Non-Executive Independent Director. - Noted change in designation for Mr. Subramanyam Adivishnu and Mr. P. Venkateswara Rao. - Scheduled the 29th Annual General Meeting for September 21, 2026.

- Board Meeting held on August 26, 2026, approved: - Issue of Bonus Shares in 1:1 ratio (1 equity share for every 1 held). - Recommended Final Dividend of ₹3/- (60%) per equity share for FY 2025-26. - Increase in Authorized Share Capital from ₹20 Crores to ₹40 Crores. - Appointment of Mr. Rana Pratap Janumahanti as Whole Time Director (Marketing and Strategy). - Appointment of Mr. Chintamaneni Vasant Kumar Roy as Non-Executive Independent Director. - Change in designation for two Deputy Managing Directors to Technical Director and Commercial Director. - 29th Annual General Meeting scheduled for September 21, 2026.

- Approved 1:1 bonus equity shares and a final dividend of ₹3/- per share for FY2025-26. - Authorized share capital increased from ₹20 Crores to ₹40 Crores. - Appointed Mr. Rana Pratap Janumahanti as Whole Time Director (Marketing & Strategy) and Mr. Chintamaneni Vasant Kumar Roy as Independent Director. - 29th Annual General Meeting scheduled for September 21, 2026.

- Concall Schedule - Concall Date: August 10, 2026 - Concall Time: 11:00 AM to 03:00 PM IST

New Filing detected. See link for details.

- Audio recording of the Conference Call for Investors held on July 27, 2026, to discuss Q1FY27 results has been uploaded on the company's website.

- Consolidated Revenue ₹300.45 Cr vs ₹240.56 Cr (▲25% YoY) - EBITDA ₹56.43 Cr vs ₹47.38 Cr (▲19% YoY) - PAT ₹25.57 Cr vs ₹22.40 Cr (▲14% YoY) - EBITDA Margin 18.78% vs 19.70% (▼92bps)

- Consolidated Revenue ₹300.45 Cr vs ₹240.56 Cr (▲24.90% YoY) - EBITDA ₹56.43 Cr vs ₹47.38 Cr (▲19.10% YoY) - PAT ₹25.57 Cr vs ₹22.40 Cr (▲14.15% YoY) - EBITDA per kg reached a historical high of ₹46.68 (vs ₹41.64 YoY), indicating improved margins.

- Revenue ₹300.45 Cr vs ₹240.56 Cr (▲24.90% YoY) - EBITDA ₹56.43 Cr vs ₹47.38 Cr (▲19.10% YoY) - PAT ₹25.57 Cr vs ₹22.40 Cr (▲14.15% YoY) - EBITDA Margin 18.78% vs 19.70% (▼92bps)

- Concall Schedule - Concall Date: Monday, July 27, 2026 - Concall Time: 4:30 PM (IST)

- Trading window closed from July 01, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ended June 30, 2026. - The Board Meeting date for approving the financial results will be intimated in due course.

- Concall Schedule - Concall Date: June 18, 2026 - Concall Time: 02:15 PM (IST)